Member Info for DD77

Marginal improvement and revenue decreased. There were plenty of warning signals in that RNS which made me think they’re setting up for not achieving FY outcome of cash flow positive and single digit revenue growth

So pretty reassuring and positive update. Strong revenue growth, should see a positive SP reaction. The one thing I did not like was the absence of any mention about positive cash flow or if we’re profitable yet which the market is undoubtedly keen to see

I'm consistently amazed by the strength of the SP here. From the start of the year to now is flabbergasting. And I expected a strong pull back after the insurance announcement and the fact we'd have to raise a not insubstantial amount of extra capital, yet here we are at new highs. £431m MCAP.

But who is buying? We've not had any notification of change in institutional investors and I don't believe all this buying is retail investors............

Impressed by the seemingly straightforward integration of Adelicious. I'm sure there'll be stumbling blocks along the way but the advantage of being a tech business if that it shouldn't be a cumbersome integration and appears the benefits will be accretive almost immediately

For a tech business, and a podcast one with the name Audioboom, the fact they host an investor presentation with such poor audio output connection is frankly embarrassing

How many warrants outstanding?

As the months tick by, without any meaningful commercial progress (deals signed, sealed and delivered, with confirmed order numbers), the chances of a placing increase further. They're burning through c. £350k each month and had £1.4m at the end of April. This means cash will only last till September............

Really just rising back to its natural level. It's been dragged down below 30p, primarily because of the warrants deadline on 28th July. I expect to see this back above 30p in the coming weeks, when the deadline has passed and we get further company updates, which are due

Totally agree that the positives outweigh the negatives. It does raise the question of where this leaves the relationship with Everdura in Taiwan...........

Https://www.ft.com/content/51c2016a-28f3-4600-9e08-a491410d34a9

No valuation was mentioned, he just said any offers in the next 12 months would likely undervalue the business, but he would expect a knockout offer in 24-36 months. It's all just hot air without any concrete (and profitable) business wins

Angus didn't read out my question on headcount numbers 23 vs 24 vs 25. He has a habit of avoiding awkward questions. It's clear they heavily recruited their sales team and are now heavily culling it, however it would have been useful to see some granularity on this ill informed decision, particularly as the SP is now a quarter of what it was back then

Angus just can't help himself.................said he's expecting a knock out offer for the company in 24-36 months. Let's hope it's better than his last prediction

This the same chairman that said they'd knock it out the park?

I expect any rise will be limited until the warrant deadline on 28th July is surpassed

Agreed Smartinvestment. It has been oversold but for good reason - the market wants to know how ITX is going to achieve revenue growth and market traction, when it's turned away (partially) from it's main customer. This is a welcome announcement. Now we need to see sales growth to support this. Some marketing/PR would also no doubt assist. This has been in the doldrums a while, but can soon turn due to the low free float.

It's a sign that a fund raise is imminent

It appears pretty sustained buying, as opposed to previous sporadic bursts...................it would suggest some sort of leak perhaps, particularly given there's still a funding issue to be addressed

No real surprises, positive that they’re still expecting to be profitable and cash positive in H2 (which we’re already 2 months into, so they should have an accurate steer) but it still seems a lot of jam tomorrow, which is what we’ve heard over the past 2+ years

That reveals more about your level of incompetence than anything else, if you failed to deliver on a £2-3m marketing budget and then blamed it on not receiving enough funds.

The difference is I’ve done it for small start ups and you can be quite resourceful, even with an omnichannel approach. The remuneration can be weighted to share incentives and commission to reduce the upfront capital costs. You don’t need millions, I’ve achieved it on budgets of £100-200k.

As to your question about what I’m doing here, I’m a long term investor and looking for a return on that like everyone else here……..which it’s apparent is now entirely predicated upon ByHealth delivering because IF is totally out of his depth